Implementation of an evidenced-based opioid treatment program to improve maternal-child outcomes in Eastern Kentucky by Rice, Jordan
University of Kentucky 
UKnowledge 
Theses and Dissertations--Public Health (M.P.H. 
& Dr.P.H.) College of Public Health 
2018 
Implementation of an evidenced-based opioid treatment program 
to improve maternal-child outcomes in Eastern Kentucky 
Jordan Rice 
University of Kentucky, jhri225@uky.edu 
Follow this and additional works at: https://uknowledge.uky.edu/cph_etds 
 Part of the Public Health Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Rice, Jordan, "Implementation of an evidenced-based opioid treatment program to improve maternal-child 
outcomes in Eastern Kentucky" (2018). Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.). 204. 
https://uknowledge.uky.edu/cph_etds/204 
This Graduate Capstone Project is brought to you for free and open access by the College of Public Health at 
UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.) by an 
authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my capstone and abstract are my original work. Proper attribution has been 
given to all outside sources. I understand that I am solely responsible for obtaining any needed 
copyright permissions. I have obtained needed written permission statement(s) from the 
owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic 
distribution (if such use is not permitted by the fair use doctrine) which will be submitted to 
UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s capstone including 
all changes required by the advisory committee. The undersigned agree to abide by the 
statements above. 
Jordan Rice, Student 
Dr. Robin Vanderpool, Committee Chair 
Dr. Corrine Williams, Director of Graduate Studies 
	
	
Rice 1 
 
 
 
 
 
 
 
 
 
 
CHARM-KY:  
Implementation of an evidenced-based opioid treatment 
program to improve maternal-child outcomes in Eastern 
Kentucky 
 
 
 
 
CAPSTONE PROJECT PAPER 
 
 
 
A paper submitted in fulfillment of  
the requirements for the degree of  
Master of Public Health  
in the University of Kentucky College of Public Health  
 
By 
 
Jordan Rice 
MPH Candidate 2018 
 
 
 
Lexington, Kentucky 
 
April 2018
	
	
Rice 2 
Project Abstract/Summary 
 
 
The Kentucky River Area District Health Department proposes implementation of 
CHARM-Kentucky, a treatment program for pregnant women with opioid use disorder (OUD), 
in eastern Kentucky. Over 115 Americans die each day from an opioid overdose, resulting in 
approximately 42,000 deaths in 2016. In addition to an overall increase in opioid use in recent 
years, the use of opioids in pregnancy has also increased from 1.19 per 1,000 hospital births in 
2000 to 5.63 in 2009. Opioid use during pregnancy results in poor neonatal outcomes including: 
low birth weight, preterm delivery, small head circumference, increased child maltreatment, and 
risk for long-term foster care. There are many different professionals, both medical and non-
medical, that may be involved in the treatment, care, and decision-making surrounding a woman 
with OUD and her baby. The CHARM program combines medication-assisted therapy (MAT) 
with early access to prenatal care, counseling, early child welfare involvement prior to birth, 
parenting education, nutrition support, and social services support. Participants in the program 
receive prenatal care, access to MAT, participate in mandatory substance abuse counseling, 
submit mandatory urine drug testing, attend group educational sessions relating to addiction and 
parenting, and have coordination of services by a case manager. The original CHARM program 
in Vermont has been shown to increase the number of women receiving treatment, move women 
into treatment earlier in their pregnancy, increase infant birth weights, and have more infants 
remain in the care of their mothers. CHARM-Kentucky will operate from the Primary Care 
Centers of Eastern Kentucky Clinic in Hazard, a clinic serving communities significantly 
burdened by the opioid epidemic in Kentucky. 
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Target Population and Need 
The Opioid Epidemic 
The United States (U.S.) opioid epidemic is a serious public health problem and was 
designated as a public health emergency in 2017. Over 115 Americans die each day from an 
opioid overdose, resulting in over 42,000 deaths in 20161. The rate of opioid-related deaths has 
dramatically increased, and is now more than three times the rate in 19991. The financial impact 
of the epidemic is estimated at $78.5 billion annually in healthcare costs, lost productivity, and 
justice system involvement2.  
Opioids are class of substances that include both prescriptions drugs (e.g., morphine, 
oxycodone, hydrocodone, methadone, fentanyl) and illicit drugs (e.g., heroin and other synthetic 
drugs). Opioids are highly addictive because they create a sense of euphoria, but they also cause 
sedation, respiratory depression, and decreased gastrointestinal motility3. Opioid use disorder 
(OUD) is defined as “a pattern of opioid use characterized by tolerance, craving, inability to 
control use, and continued use despite adverse consequences4.” Opioid use is often accompanied 
by an unstable lifestyle, decreased social structure, and drug-seeking behaviors, which 
collectively increase the risk of injury and death5. The increase in opioid use is associated with 
increases in adverse physical and mental health outcomes, including overdose, contraction of 
infectious diseases, risk of assault, and neonatal opioid withdrawal syndrome among infants born 
to opioid-abusing mothers.  
This growing public health concern has prompted numerous federal agencies to respond 
to the crisis. The U.S. Department of Health and Human Services (DHHS) and its agencies have 
focused on increasing access to treatment, increasing public health surveillance, and allotting 
research dollars to address the issue. The Centers for Disease Control and Prevention released 
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the Guideline for Prescribing Opioids for Chronic Pain in 20166. The Food and Drug 
Administration (FDA) issued guidance for the pharmaceutical industry to develop generic 
versions of abuse-deterrent formulation of opioid medications and updated warnings and safety 
information on existing opioid medications7. The Drug Enforcement Agency (DEA) rescheduled 
hydrocodone containing products to a more restrictive controlled substance category8. Many 
states, including Kentucky, have enacted prescription drug monitoring programs to track 
controlled substance prescriptions as well as improve prescribing and dispensing9. Despite these 
efforts, the opioid crisis continues to ravage the country.   
 
Opioid Use During Pregnancy 
In addition to an overall increase in opioid use in recent years, the use of opioids in 
pregnancy has also increased from 1.19 per 1,000 hospital births in 2000 to 5.63 in 200910. 
Opioid drugs are small molecules that easily cross the placental barrier to the fetus3. Neonatal 
abstinence syndrome (NAS) is a withdrawal syndrome experienced by infants at birth after 
exposure to drugs, primarily opioids, in the womb. In 2012, a baby was born with NAS in the 
U.S. every 25 minutes11.  
Opioid use during pregnancy results in poor neonatal outcomes including: low birth 
weight, preterm delivery, small head circumference, increased child maltreatment, and risk for 
long-term foster care5,10,12. Because opioid receptors are most common in the central nervous 
system and gastrointestinal tract, opioid-related NAS is characterized by a high-pitched cry, 
tremors, irritability, fevers, weight loss, and seizures. Babies born with NAS require more 
expensive hospital stays, and are more likely to be covered by Medicaid10,11. Overall, babies that 
require treatment for NAS have an average stay of 17-23 days compared to an average of 24-48 
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hours for normal, healthy infants5. Babies that do not respond to non-pharmacologic therapy, 
such as skin-to-skin contact and low stimulus environments, are treated with medications, such 
as morphine and methadone, that are tapered over time. Additionally, infants with NAS that are 
exposed to more than one substance during development are even more difficult to treat.   
Women with OUD face many barriers to treatment, but without treatment, they face 
increased risk of pre-term delivery, delivering low birth weight infants, and transmitting 
infectious diseases to their infant13. Laws that sanction pregnant women with OUD and the 
shame associated with the condition drive women away from available care or from seeking care 
in the first place13. Many women present for medical care very late in pregnancy or when they 
are in labor.  
 
Medication-assisted therapy 
Medication-assisted therapy (MAT) is the use of a medication – combined with substance 
abuse counseling – to treat OUD. MAT is recognized as the most effective treatment for OUD, 
including in pregnant women. MAT is widely accepted as the recommended standard of care and 
is recognized as best practice by the American College of Obstetricians and Gynecologists4,5. 
MAT reduces cravings and withdrawal symptoms, aiming to decrease the rates of relapse to 
illicit drug use. Illicit opioid use can subject the fetus to repeated withdrawal episodes between 
uses. Withdrawal, whether supervised or unsupervised, is not recommended because it can cause 
spontaneous miscarriage and is associated with higher rates of drug relapse4,14. The positive 
benefits of MAT are not only apparent during pregnancy, but continue after the child is born. 
Mothers who are stable on therapy are encouraged to breastfeed, further improving the health of 
the child14.  
	
	
Rice 6 
Two common medications used in MAT have opioid receptor activity and are considered 
opioid replacement therapy. These are methadone, a long-acting opioid receptor agonist, and 
buprenorphine, a partial opioid receptor agonist. Methadone and buprenorphine are both taken by 
mouth daily. Methadone has long been the standard therapy for MAT, however, buprenorphine 
has been increasingly prescribed due to emerging data supporting its use15,16. Methadone is 
dispensed daily by certified opioid treatment programs. Buprenorphine can be obtained by 
prescription at a pharmacy. Both methadone and buprenorphine are acceptable therapy options, 
and the choice between agents is made by physicians based on the characteristics and needs of 
the patient. Although babies born to mothers stabilized on MAT may still experience NAS, the 
benefits of the therapy still outweigh the risks that face the fetus in unsupervised opioid use. The 
risks and benefits of MAT should be discussed in-depth with each individual.  
 
The Kentucky River District 
The Appalachain region of 
Kentucky has been at the 
forefront of the opioid epidemic. 
Per Kentucky Revised Statute 
211.687, cases of NAS are 
required be reported to the 
Kentucky State Health 
Department17. From 2009-2012, the highest incidence of NAS in the U.S. was in the East South 
Central region, including Kentucky, Tennessee, Mississippi, and Alabama11. The number of 
newborns with NAS in Kentucky has increased 23-fold since 2001, with about 80% of these 
Figure	1.	NAS	Rate	in	Kentucky	Area	Development	Districts. 
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births covered by Medicaid18. In 2015, there were over 110 cases of NAS each month across the 
state. As noted in Figure 1 the Kentucky River Area Development District (KRADD), an 8-
county region in southeastern Kentucky, had the highest rate of NAS among all Kentucky Area 
Development Districts, with an estimated 43.1-63.9 cases per 1,000 births reported in 2015, 
compared to 24.3 at the state and national level respectively18.  This region includes Breathitt, 
Knott, Lee, Leslie, Letcher, Owsley, Perry and Wolfe counties. The KRADD has been 
significantly impacted by the opioid epidemic. These counties are socioeconomically 
disadvantaged and have some of the poorest health outcomes in the nation. A comparison of 
relevant indicators can be found in Table 1. 
 
Table 1. Comparison of the Social and Health Indicators of the KRADD, Kentucky, and the U.S. 
 KRADD Kentucky U.S. 
Social Indicators  
Median household income19 $28,416 $43,740 $53,046 
Medicaid enrollment (% of population)19,20  42% 22% 25.4% 
High school graduation, 201619,21  71% 88.6% 84.1% 
Drug arrests (per 100,000)19  1,549 1,476  
Health Indicators  
Total mortality rate (per 100,000)22 1,231 909 823.7 
Infant mortality rate (per 100,000 live births)23,24 700 670 587 
Proportion receiving adequate prenatal care19 64% 67% 77.1% 
Low birth weight19,25  (% of live births) 11% 9% 8% 
Proportion of deliveries covered by Medicaid26 -- 46% 42.6% 
 
Healthcare services in the district, including opioid treatment centers, are limited. 
Respondents to the 2015 Hazard Appalachian Regional Health (ARH) Community Health Needs 
Assessment identified that “mental health, addiction treatment, and a birthing center” were 
among the services that should be provided in Perry County27. The Hazard ARH Regional 
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Medical Center Psychiatric Center is the state designated acute mental health facility for 21 
counties in eastern Kentucky27. In 2017, there were 214 physicians certified to prescribe 
buprenorphine to treat up to 30 patients, and 49 physicians certified to treat up to 100 patients28. 
The only outpatient opioid treatment program in the Kentucky River District is the Behavioral 
Health Group Center in Hazard, KY29. There are only five OB/GYN providers in the entire 
district19. Hospitals in the area include: Hazard ARH Regional Medical Center, Jenkins 
Community Hospital, Kentucky River Medical Center (Jackson), Mary Breckenridge Hospital 
(Hyden), and Whitesburg ARH Hospital. 
 
Program Approach 
The CHARM Collaborative 
There are many different professionals, both medical and non-medical, that may be 
involved in the treatment, care, and decision-making surrounding a woman with OUD and her 
baby. Professionals or organizations that may influence a woman’s care include obstetricians, 
addiction specialists, child welfare workers, judicial system representatives, local hospital 
systems, or clinics. Each of these professionals and organizations have different priorities and 
policies that often lead to a disjointed or conflicting approach to ensuring the best outcome for 
mother and child.  
The Children and Recovering Mothers (CHARM) Collaborative began in Vermont in 
2002 as an effort to address medical disparities and improve maternal and child health outcomes 
in rural areas. It began when an addiction specialist opened the first methadone clinic and 
coordinated care with a local obstetrician. The program attempts to address the five-points of 
intervention framework to help reduce the potential harm of prenatal substance exposure 
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recommended by the National Center on Substance Abuse and Child Welfare30: pre-pregnancy, 
prenatal, birth, neonatal, and adolescence. CHARM not only addresses substance use, but also 
provides a coordinated, comprehensive approach to other medical and mental health conditions, 
and socioeconomic barriers that may co-exist with substance use disorder. Women with OUD 
often come from unstable backgrounds, with little social and financial support, and have a 
history of sexual or physical abuse14. This program emphasizes prevention to promote a safe 
pregnancy, birthing experience, and childhood. The program combines MAT with early access to 
prenatal care, counseling, early child welfare involvement prior to birth, parenting education, 
nutrition support, and social services support. Participants in the program receive prenatal care, 
access to MAT, participate in mandatory substance abuse counseling, submit mandatory urine 
drug testing, attend group educational sessions relating to addiction and parenting, and have 
coordination of services by a case manager. The CHARM Needs Assessment team consisting of 
members of key services in the program meets monthly to identify gaps in care and aid in the 
transitions of care of the participants. Since 2002, the Vermont CHARM Collaborative has 
grown to a multidisciplinary group of 11 agencies that work together across multiple clinics to 
identify and provide coordinated care for pregnant women with OUD and their babies from 
conception through the beginning of the child’s life14. Currently, the Vermont-based CHARM 
Collaborative serves 200-250 women and their families annually.  
This community approach to opioid addiction in pregnancy has been shown to increase 
access to care and improve neonatal outcomes12,14. The original study by Meyer and colleagues 
compared women at a single institution receiving medication assisted therapy (methadone 
administration) to women that received medication assisted therapy with improved coordination 
of ancillary services. This study was conducted via retrospective chart review of the patient’s 
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medical records. Over a 6-year study period, the Vermont CHARM program increased the 
number of women receiving treatment for OUD at the clinic from 15 in the first two years of 
program implementation to 51 women in the sixth year of the program. Women also received 
treatment earlier in their pregnancy, starting treatment at 21.9 weeks during the first two years 
compared to at 4 weeks in the sixth year of the program. Infant birth weights were significantly 
higher in women who participated in the CHARM program compared to women who only 
received opioid substitution therapy; 3016 grams vs 2816 grams, respectively. More than 90% of 
infants born to women in the CHARM were discharged from the hospital in the care of their 
mother compared to 69% of infants born to mothers who were not in the program. Furthermore, 
women in the CHARM program were significantly more likely to retain custody of the infant at 
1 year of age: 84.8% versus 62.5%.12. It is important to be cognizant of the fact that confounding 
variables may have impacted the outcomes of this study, including the increased availability and 
convenience of buprenorphine compared to methadone over the study period. As the authors 
recognize, the outcomes are likely due to the synergism of multiple factors. Based on the 
outcomes of this study, the CHARM program was recommended in 2016 as a collaborative 
strategy for treatment of pregnant women with OUD by the Substance Abuse and Mental Health 
Services Administration (SAMHSA)14. There are other U.S. programs similar to the Vermont 
program, including in Ohio, North Carolina, and in central Kentucky, however, there are no 
studies or outcomes that have been published on these programs to date.  
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CHARM-KY 
The Kentucky River District Health 
Department (KRDHD) will implement CHARM-KY 
to meet the needs of opioid-dependent pregnant 
women in the KRADD. CHARM-KY will be modeled 
after the Vermont CHARM project with minor 
adaptations. Some ideas for CHARM-KY have also 
been adapted from PATHways/Beyond Birth, a similar 
program for pregnant women with OUD operating in 
Lexington, Kentucky through the University of Kentucky College of Nursing. The CHARM-KY 
Collaboration will be comprised of agencies and resources in the Kentucky River District and the 
state of Kentucky. These partnering agencies include: Primary Care Centers of Eastern 
Kentucky, Mountain Comprehensive Care, UK North Fork Valley Community Health Center, 
Department of Community Based Services, Perry County Drug Court, Kentucky Health Access 
Nurturing Development Services (HANDS), and Hazard Appalachian Regional Health (ARH) 
Regional Medical Center. This collaboration will provide a means to efficiently share client-
specific information and coordinate care in the KRADD. A community advisory group (CAG) 
will be established to guide implementation of CHARM-KY. Members of the CAG will include 
representatives from the health departments in each county, Hazard ARH, the Center for 
Excellence in Rural Health, local elected officials, the justice system, the police force, a domestic 
violence program, and the Perry County Unlawful Narcotics Investigators, Treatment and 
Education program. A further description of these partnering agencies and their role in the 
program is discussed in Partnerships and Collaboration. 
Figure	2.	The	Kentucky	River	Area	Development	District. 
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Figure	3.	Primary	Care	Centers	of	Easter	Kentucky	Clinic	in	Hazard,	KY. 
The CHARM-KY program will operate from an established clinic, Primacy Care Centers 
of Eastern Kentucky (PCCEK), in Hazard, KY (Figure 2). The PCCEK clinic currently offers 
on-site services including prenatal care, women’s health, pediatrics, and behavioral health31. The 
PCCEK clinic has already been providing prenatal care to our target population and will be well 
equipped to adopt the CHARM-KY program model. Using the clinic as a hub for CHARM-KY 
services will allow women to receive almost all aspects of care at one site. At this clinic, women 
will attend prenatal appointments, substance abuse counseling appointments, and group 
education sessions. Additionally, the staff at PCCEK will be trained to connect CHARM-KY 
participants to social services.  
 
CHARM-KY: Enrollment and orientation 
Women can be referred to the CHARM-KY program by any source: their local health 
department, a substance abuse counselor, a hospital emergency department, their primary care 
provider, a woman who is a current or former participant in the program, and/or by self-referral. 
It is anticipated that the majority of participant enrollment will come from word of mouth and 
social networks, similar to enrollment methods seen in the PATHways/Beyond Birth program32. 
Women will be incentivized to refer other women needing CHARM services with a $20 gift card 
for groceries. 
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Each health department coordinator in the KRADD and community partner organization 
will be given information on how to screen and refer women to CHARM-KY. All pregnant 
women should be screened for OUD at the initial prenatal encounter, as recommended by 
ACOG4. Health departments, primary care clinics, and other points of contact for our target 
population will be informed of CHARM-KY and encouraged to use a screening tool, such as the 
4Ps Plus, to identify and refer women who may benefit from the program. The “4P’s Plus” 
screening tool has been well validated for use in pregnant women to identify alcohol use and 
drug use, with a sensitivity of 87% and specificity of 76%4,33. If screening is positive, the 
woman’s contact information will be communicated to the PCCEK clinic with her consent. The 
CHARM-KY program coordinator will contact the woman within three days of receiving 
notification from the woman or outside referral sources to establish care. During this call, the 
program coordinator will screen the woman for appropriateness in the program. Three attempts 
will be made by the PCCEK office to reach the woman to establish care.  
During a woman’s first clinic visit, a detailed medical and social history will be taken by 
the program coordinator. She will be assessed for OUD by the physician, her pregnancy will be 
confirmed, and she will be tested for infectious diseases, such as viral hepatitis and HIV. If 
pregnancy and OUD are both confirmed, the woman will be provided education on the CHARM-
KY program and given the opportunity to enroll. The woman must sign the Release-of-
Information Form, which states that she agrees that her personal information may be shared 
between all CHARM-KY agencies for coordination of care. The woman must also sign a Care 
Contract, which outlines the policies and expectations of both the providers and participants in 
the CHARM-KY program. If a woman declines to enroll in CHARM-KY, she may continue to 
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receive standard medical care, but it will not be coordinated for her by the CHARM-KY 
program.  
 
CHARM-KY: Care during the prenatal phase 
After a woman has been enrolled in the program, the woman will meet with the social 
worker to identify any social barriers that could interfere with the woman’s recovery. The social 
worker will determine the woman’s insurance coverage status, housing status, and history with 
the justice and child welfare systems. This information will be used to connect the woman to 
services to meet her basic needs. She will attend scheduled prenatal appointments, counseling 
appointments, and group education classes. It is the goal that the woman visits the PCCEK clinic 
a minimum of once per week until she is considered stable. The schedule for prenatal 
appointments will be made by the Leadership Team (see Project Management) in accordance 
with national prenatal care guidelines. In an uncomplicated pregnancy, this is typically 10 
prenatal visits34. During weeks when a woman does not have a prenatal appointment, she will be 
scheduled to attend counseling or group education sessions. Group education sessions will cover 
parenting education topics such as care of a newborn, breastfeeding, and caring for a baby with 
NAS. Each session will be led by a PCCEK staff member or another professional well versed on 
the topic (i.e., a session on domestic violence may be led by a representative from the Kentucky 
Coalition Against Domestic Violence). A list of topics to be covered during education sessions 
can be found in Appendix C. Each woman will be given a “Care Notebook” that includes a 
summary of the CHARM-KY program, a list of local resources for services (i.e., medical, 
transportation, housing, financial), forms to record medical information and child development 
milestones, and frequently asked questions about pregnancy and child care. It will also include 
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stories and encouragement from women who have participated in the program. Prior to delivery, 
the woman will be educated by a nurse certified in obstetrics about what she should expect 
during the hospital stay (e.g., possibility of neonate admission to NICU) and what she might 
need to ask for (e.g., nicotine patches if she is a smoker).  
In addition to prenatal care, the woman will receive services focused on mental health 
and OUD. The woman will be assessed and initiated on opioid replacement therapy with 
buprenorphine after enrollment. If she was on opioid replacement therapy outside the clinic, she 
will be maintained on that therapy. In addition to medication, she will be required to participate 
in substance abuse counseling with a certified drug and alcohol abuse counselor (CDAC). The 
CDAC will be staff from Mountain Comprehensive Care who will come to the PCCEK clinic to 
provide counseling services. Women will provide an observed urine drug screen at each 
appointment at the clinic in order to receive a prescription for buprenorphine. The CHARM-KY 
team will assess the woman for signs of relapse and the need for MAT dose adjustments during 
each interaction at the clinic. Women deemed to be at-risk for relapse or that have recently 
relapsed will be discussed at the monthly CHARM-KY meetings. The program will utilize a 
system of Levels to describe the level of accountability she requires. This system will allow 
CHARM-KY agencies to clearly identify what is required of each participant, and to identify 
those that require more attention. For example, if a woman has had a recent relapse or disruption 
to her home life, she may require a higher level of accountability from the CHARM-KY team. 
The Levels systems is described in Appendix A. A woman must be actively engaged in treatment 
and attending scheduled appointments to receive her prescription. Higher rates of program 
retention are anticipated due to the opportunity to obtain MAT. Relapse is an expected part of the 
recovery process. The program staff will work with the women in a supportive manner to work 
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towards recovery during difficult times. However, if a woman enrolled in CHARM-KY 
continuously uses illegal substances, misses pre-natal appointments repeatedly, or does not have 
a safe living situation, the CHARM-KY members may notify child protective services. The 
woman will be referred to an intensive outpatient or inpatient treatment center in the area.  
 
CHARM-KY: Care during delivery 
A goal for children born in the CHARM-KY program is to stay in the care of their 
mother after birth. There will be a great deal of planning prior to the birth event to increase the 
likelihood of that outcome. Women who have continued to use illegal substances during 
pregnancy or are not stable on MAT will be discussed at the monthly CHARM-KY meetings 
prior to delivery to make a plan for birth. This plan may include safety assessments conducted by 
the Department for Community Based Services Protection and Permanency to identify additional 
services needed or arrange alternative placement of the child after birth. This decreases the 
likelihood of birth crises, such as emergency custody orders, during the delivery event. Women 
who have attended at least 80% of their prenatal appointments and have been actively engaged in 
recovery, will be given a car seat.  
Women with uncomplicated pregnancies will be encouraged to give birth at Hazard ARH 
Regional Medical Center, but they may give birth at any hospital. To standardize care for 
CHARM-KY babies, a protocol will be developed by the CHARM-KY Leadership Team that 
includes guidelines for the care coordination, the mother’s pain management, screening the 
infant for NAS, and treatment for NAS symptoms. This protocol will be distributed to Hazard 
ARH Regional Medical Center and other rural hospitals in the region. When a participant arrives 
to Hazard ARH, the facility will contact the program coordinator within 24 hours to notify her of 
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the delivery. After delivery, the neonate will be screened for NAS using the validated Finnegan 
Neonatal Abstinence Scoring Tool5 and monitored for a minimum of five days. During the 
hospital stay, a drug screen will be administered to both the mother and newborn. If the baby is 
diagnosed with NAS, the facility is required to report the case to the Kentucky Department for 
Public Health for surveillance purposes, in accordance with KRS 211.67617. Babies born to 
participants will stay in their mother’s room after birth. The mother will be encouraged to take an 
active role in the care of the newborn with skin-to-skin contact and breastfeeding. Babies 
requiring treatment for NAS will be treated according to a protocol developed by CHARM-KY 
providers.  
 
CHARM-KY: Care post-partum 
Babies born to CHARM-KY mothers will continue to receive care until 18 months, and 
the mothers can continue to receive coordinated services for up to eight weeks after delivery. 
Women in CHARM-KY will be scheduled for an appointment within 1 week of delivery. This 
ensures that the mother is continuing the safe care plan following birth and that the infant is 
receiving appropriate medical care. At this point, the PCCEK clinic pediatric staff will assume 
care of the baby. The mother will remain on MAT, and continue to attend substance abuse 
counseling and group education sessions. CHARM-KY will partner with the health departments’ 
Health Access Nurturing Development Services (HANDS) program to provide in-home nursing 
visitations to aid in the transition of parenting at home.  
After a woman’s participation in the CHARM-KY program ends, the case navigator 
helps the patient establish care with a new MAT provider. This connection to care outside of the 
program will prevent interruption of treatment. If a woman participated in HANDS, attended at 
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least 80% of the recommended appointments and clinic visits, and actively engaged in recovery, 
she will be given a gift certificate for 6-months worth of diapers. Additionally, she can elect to 
complete training to become a peer support specialist. This will allow her to remain engaged in 
the program, while providing valuable support to women still enrolled. In this role, she can earn 
$25 gift cards for additional infant supplies.  
 
Implementation 
The first quarter of the first year will be used as a program planning phase. The program 
planning phase will be utilized to recruit and hire staff, conduct a modified community health 
needs assessment, and set goals. During this phase, program coordinators from the Vermont 
CHARM program will be invited to Kentucky to train CHARM-KY leadership and staff. The 
second quarter of year one will be used to train staff and meet with the CAG. Women can enroll 
and participate in the program from quarter three of year one until quarter two of year three. This 
allows time for the staff to be adequately trained before enrolling participants. Ending enrollment 
with six months left in the grant allows time for staff to conduct data collection and outcome 
evaluation analyses. A complete Gantt Chart can be found in Appendix E. An overview of the 
inputs, activities, outputs, and outcomes can be found in the Logic Model in Appendix D. 
 
CHARM-KY Adaptations 
The Vermont CHARM program is over 12 years old and has had a significant amount of 
time to implement all pieces of the program that make up the current iteration of CHARM. 
CHARM-KY will be implemented as a pilot program operating from a single clinic to determine 
the feasibility of the program in the Appalachian region with selected community partners. 
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Additions to the CHARM-KY program, not present in the Vermont program, will be based on 
the availability and usefulness of services in the area. For example, dental services were not 
included in the CHARM collaboration in Vermont. Poor dental health is associated with poor 
birth outcomes35. CHARM-KY will connect women to dental services provided by individuals 
familiar with the program and its participants. Although the Vermont program did not utilize a 
home visitation service for participants, the decision to partner with HANDS was made to 
increase the supportive parenting services available to participants. The Vermont CHARM 
program originally utilized both methadone and buprenorphine for MAT. However, since the 
original publication, there have been many published studies supporting the use of 
buprenorphine over methadone16. Due to the barriers to administering methadone, the CHARM-
KY providers will only utilize buprenorphine therapy for MAT.  
 
Potential Barriers to Implementation 
Barriers to program implementation were identified from those experienced in Vermont 
and at the PATHways/Beyond Birth program. An anticipated barrier to the success of CHARM-
KY is the potential disagreement regarding treatment practices and legal implications between 
agencies involved in the program. Reconciling differing views on legal, medical, and social 
concerns will be important to maintain a standardized program approach. A solution to address 
this barrier will be to include all partnering agencies in the initial planning discussions, and going 
forward spend 10-15 minutes during each meeting for continuing education and cross-training 
among members. These mini-educational sessions will be focused on educating members of the 
CHARM-KY on issues important to the group. These may include: what constitutes an 
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intervention from child protective services, what laws prevent and allow treatment with MAT, 
and what services can be provided by social workers.  
Another barrier anticipated in this program is the transient nature of our target population. 
Clinic staff will maintain multiple contact phone numbers, email addresses, and mailing 
addresses for women participating in the program, including asking the women permission to 
contact family members as needed. Many women eligible for CHARM-KY may also have been 
“fired” or discharged from the care of their community providers, including their OB/GYN 
provider, due to their substance use. This can generate a distrust of the medical system and 
potentially make it more difficult to engage women in care. Because few treatment facilities 
accept pregnant women, the CHARM-KY program will eliminate that barrier to accessing care 
for our target population. Our social worker will coordinate transportation and insurance 
coverage for women to increase the likelihood of participation. Women will be encouraged to 
bring other children they may have in their care to the clinic so that childcare is not a barrier. A 
significant barrier many women face is that they may have partners or family members who are 
also substance abusers. A full effort from the CHARM-KY collaboration members will be 
necessary to connect the woman’s partner or family member with care outside the PCCEK clinic, 
or at minimum decrease the interference on the woman’s recovery. Internal barriers faced by this 
population include co-existing depression, anxiety, and guilt regarding their substance use. 
Women will be required to see a counselor regularly, and this counselor will be utilized to build 
a supportive community with other women in the program. Ultimately, the clinic staff will be 
trained in-depth on the stressors faced by women in this population to decrease any 
stigmatization they may feel. To address participant drop-out, an effort will be made to contact 
women after they stop participation in the program to determine the reason(s). If the reason is 
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related to barriers to accessing care, the social worker will work with the women to resolve the 
issue (i.e., transportation, housing instability) in an effort to reengage her in the program. If the 
woman declines to become reengaged, the program coordinator will record the primary reason 
and use this information to guide programmatic refinements. If women do not like the program’s 
structure, they will be connected to the nearest care provider in the area for prenatal and 
addiction medicine services.  
 
Sustainability of CHARM-KY 
CHARM-KY will be primarily implemented by personnel who are already providing care 
or services in the area. Partnering with established agencies in the region that have a vested 
interest in the program’s outcomes will provide a larger network of support that can sustain the 
program in the long-term. Financially, most personnel will be reimbursed for their services by 
Medicaid. The program also depends heavily on Medicaid prescription drug insurance plans to 
pay for the participant’s medications. Because of this, it is crucial that CHARM-KY maintain an 
active and productive relationship with the Department for Medicaid Services through the 
Department of Community Based Services. A potential barrier to program implementation is the 
capacity of professionals in the region to take on additional caseloads. This is a valid barrier that 
could diminish the potential impact of the program, and program leadership will need to alter 
program recruitment efforts based on staff capacity to handle additional participants. In the long-
term, the program may need to redistribute funds in the budget to recruit more professionals to 
the area, including social workers and medical professionals. A future solution to this issue may 
be the use of telehealth to provide services from off-site providers at the University of Kentucky, 
for example. In 2018, the Kentucky state legislature heard bills in both the House and the Senate 
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regarding Telehealth Services. The use of telehealth services has been recommended to increase 
access for pregnant women in rural areas36.  
 
Partnerships & Collaboration 
Community Advisory Group (CAG) 
The success of CHARM-KY will be dependent on the collaboration of the multiple state 
and local agencies. To form a CAG, we have identified key members of the community who are 
familiar with the people, resources, and the way of life in the area. By including community 
stakeholders in the development of the intervention, we anticipate the likelihood of success in 
implementation. The mayor of Hazard, Jimmy Lyon, has voiced support in the past for 
interventions addressing the region’s opioid problem and he can provide insight into the city’s 
inner workings.  Inviting the director of the Center for Excellence in Rural Health to serve on the 
CAG is important to learn more about program implementation in the district and what programs 
have been attempted in the past. Participation from the Hazard Chief of Police will garner 
necessary support from the criminal justice system. The LKLP Safe House in Hazard provides 
shelter and services to domestic violence victims and their children, a population that may be 
served by our intervention. Finally, asking a coordinator from each county health department to 
participate in the CAG is critical to making connections in all of the communities our program 
will reach. A complete list of CAG members can be found in Table 2.  
Table 2. Community Advisory Group (CAG) Members 
Administrator, Eastern Mountain Protection & Permanency/DCBS Service Region 
Chairman, Perry County Board of Education 
Chief of Police, Hazard, KY 
Coalition Coordinator, Perry County Unlawful Narcotics Investigations, Treatment, and 
Education (UNITE) 
Community CEO, Hazard Appalachian Regional Health Regional (ARH) Medical Center 
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Coordinator, Breathitt County Health Department 
Coordinator, Knott County Health Department 
Coordinator, Lee and Owsley County Health Department 
Coordinator, Leslie County Health Department  
Coordinator, Letcher County Health Department  
Coordinator, LKLP Safe House Domestic Violence Program 
Coordinator, Perry County Health Department  
Coordinator, Wolfe County Health Department  
Director, Center for Excellence in Rural Health  
Field Representative for Congressmen Hal Rodgers, Hazard District 
Mayor, Hazard, KY 
Program Supervisor, Perry County Adult Drug Court 
 
CHARM-KY Collaboration Partners 
Collaboration partners not only provide additional insight into the community our 
program will serve, but they will play an active role in implementation of our intervention. All 
members of the collaboration already work with members of the CHARM-KY target population 
in some capacity. Dr. John McKinney of the PCCEK clinic has confirmed interest in the 
CHARM-KY program and agreed to use his clinic as the hub for services. Because his clinic 
already serves pregnant women with OUD, he has a vested interested in the outcomes of 
CHARM-KY. Local social services, including the Department of Community Based Services, 
are already working with our target population. Including the Perry County Protection and 
Permanency Family Services Office and the Eastern Mountain Family Support Services Office 
will facilitate the coordination of child welfare, violence prevention, nutrition support services, 
and Medicaid/CHIP enrollment services for CHARM-KY participants. Prescription insurance 
coverage for eligible women and children is vital to the success of the program. The completion 
of prior authorization paperwork is required by most insurance plans to cover medications, such 
as buprenorphine, used in MAT. Completing prior authorizations requires communication 
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between the pharmacy, provider, and insurance company. It can take anywhere from days to 
weeks, and is often a barrier to the patient accessing their prescribed medication. Uniting the 
Pharmacy Care Center with the other partners in this collaboration will expedite this process. 
Including Hazard ARH in the collaboration is important to increase communication between 
hospital and community providers before and during births. The HANDS program is a well-
established home visitation program for new or expectant parents to help build a healthy and safe 
environment for the child’s development, and serves over 10,000 families across Kentucky each 
year37. This existing program’s experience in facilitating home visitation, working with pregnant 
women and new mothers, and providing connection to local services will be beneficial in 
implementing these aspects of CHARM-KY. Table 3 describes the roles of CHARM-KY 
collaboration members. 
Representative CHARM-KY Collaborative 
Members/Agencies 
Member/Agency Role 
Jordan Price, MPH Program Coordinator; 
CHARM-KY 
Director of CHARM-KY Collaboration 
Coordinator of care services for participants 
Leslie Atkins, BSN, 
RNC-OB 
Program Director; Pregnancy 
and Beyond program, 
PCCEK Clinic 
Provide nursing services and education to 
participants 
John McKinney, MD Physician; PCCEK Clinic  Provide prenatal and mental healthcare 
Provide physician and nursing staff 
Representative, LCSW Case navigator; PCCEK 
Clinic and Mountain 
Comprehensive Care, Hazard 
Facilitate case management and connection 
to social services 
Jill Powell, CDAC Clinic Coordinator; 
Mountain Comprehensive 
Care, Hazard 
Provide MAT after graduation from program 
 
Sharon Barker, DMD Dentist; UK North Fork 
Valley Community Health 
Center 
Provide dental services for participants 
Valerie Smith Supervisor; Perry County 
DCBS Protection and 
Coordinate child welfare and violence 
prevention 
Coordinate Medicaid & KCHIP enrollment 
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Permanency Family Services 
Office 
Coordinate assistance for domestic violence 
victims 
Francis Walters Supervisor; Eastern 
Mountain DCBS Family 
Support Services Office 
Coordinate Supplemental Nutrition 
Assistance and WIC Program benefits  
Facilitate Medicaid enrollment 
Elizabeth Wells Circuit Court Judge; Perry 
County Adult Drug Court 
Aid in navigation for women in justice 
system 
Jacquelyn Williams KRAD Coordinator; 
Kentucky Health Access 
Nurturing Development 
Services (HANDS) Program 
Provide education on parenting skills and 
child health 
Conduct home health nurse visits after birth 
Margret Timothy Director of Community 
Engagement; Hazard ARH 
Regional Medical Center 
Connection to local acute care services  
 
Karen Burt, PharmD Pharmacist; Pharmacy Care 
Center and PCCEK 
Provide pharmacy services and coordination 
of medication access 
 
All member organizations participating in CHARM-KY must sign a memorandum of 
understanding to share information regarding each of the individuals enrolled. Shared 
information may include name, living situation, health history, psychiatric history, substance use 
history, criminal history, and previous encounters with child protective services. The CHARM-
KY providers will meet once monthly for 2 hours to discuss patient cases and program 
implementation. This will increase communication between providers and enhance the 
coordination of care. This allows for time for team members to disclose pertinent information 
that they have learned regarding a participant or their situation with the larger group. During 
these meetings, each person involved in the project will provide status updates to identify where 
problems or delays in program implementation.  
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Performance Measures & Evaluation 
Overview 
The purpose of the evaluation will be to assess the program’s feasibility and provide that 
information to CHARM-KY stakeholders. The primary goal of CHARM-KY is to improve 
maternal-child health outcomes in eastern Kentucky, and evaluation of our program will be 
guided with this outcome in mind. Conducting both process and outcome evaluation of 
CHARM-KY will enable program leadership to monitor the program’s progress towards its goals 
and use that data to improve the program. Our Evaluation Team will be by comprised of our 
Program Director, Dr. Scott Lockard; our Program Coordinator, Jordan Rice; a current or former 
participant of the PATHways program in Lexington; an evaluation consultant from the Kentucky 
Department of Public Health; and a biostatistician from the University of Kentucky College of 
Public Health. Evaluation activities for CHARM-KY will be guided by input from stakeholders 
in our program: 
• CAG members 
• CHARM-KY collaboration partners 
• Staff of the PCCEK clinic 
• Members of our target population 
• Funding agency  
Formative Evaluation 
 Before enrolling the first participant, we will conduct a focus group with each of our 
stakeholder groups including (1) women from our target population, (2) proposed staff, (3) 
members of the CHARM-KY collaboration agencies, and (4) members of the CAG to assess the 
feasibility and appropriateness of CHARM-KY and its components. Potential topics of 
evaluation may include: What would you like this program to accomplish? How could we get 
you to enroll in the program? What is important to you about this program? What are your 
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concerns about this program? How will you use the results of the program evaluation? Program 
materials, such as the Care Notebook, will be evaluated in these sessions as well. Conversations 
will be recorded, professionally transcribed, and coded for themes by the program coordinator. 
Results of the focus groups will be used to inform the development of implementation and 
outcome measures. 
 
Process Evaluation 
The program will utilize process evaluation as recommended by the CDC38 to determine 
if the program is implemented as planned, what resources are being utilized, and who is reached 
as a result. To evaluate implementation of our program, the Evaluation Team will monitor and 
analyze a variety of components, including measures related to operations, staff engagement, and 
participant engagement. Results from process evaluation measures will be compiled and 
presented to stakeholders at the collaboration meetings each quarter, and to the funding agency 
on an annual basis. A complete description of these components can be found in Table 4.  
Process Measure Data Source(s) Responsible Person(s) Time Frame 
Program operations 
CAG perception of CHARM-KY 
program prior to program initiation 
Focus group; 
Key informant 
interviews 
Program coordinator Quarter 1, 
Year 1 
Number of staff trained on CHARM-KY Training log Program coordinator Quarter 2, 
Year 1 
Proportion of women who screen 
positive for OUD in the community and 
enroll in CHARM-KY 
Referral form Program coordinator Quarterly 
Content of group education sessions Observation Program coordinator Quarterly 
Participant referral source Referral form PCCEK manager Quarterly 
Participants seen within 1 week of 
referral 
Intake form PCCEK manager Ongoing 
Staff satisfaction and engagement 
Collaboration members’ perception of 
appropriateness & effectiveness of 
CHARM-KY collaboration 
Partnership 
survey 
Program coordinator Quarterly 
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Teamwork of CHARM-KY collaboration 
members 
Partnership 
survey; 
Meeting minutes 
Program coordinator Quarterly 
Engagement of staff at PCCEK Staff survey Program coordinator Quarterly 
Number of partners present at CHARM-
KY meeting 
Meeting 
attendance log 
Program coordinator Monthly 
Participant satisfaction and engagement  
Proportion of women completing 
CHARM-KY program 
Participant 
record 
Program coordinator Quarterly 
Reason why participants left program Participant 
record 
PCCEK manager Ongoing 
Participants’ perception of group 
educational sessions 
Participant 
survey 
Program coordinator Quarterly 
Number of women enrolled in CHARM-
KY 
Participant 
record(s) 
Program coordinator Monthly 
Number of participants at group sessions Group session 
attendance log 
Group session leader Ongoing 
Number of scheduled appointments 
attended  
Participant 
record 
PCCEK manager Quarterly 
Number of recommended group sessions 
attended 
Group session 
attendance log 
PCCEK manager Quarterly 
Participant’s perception of CHARM-KY Participant 
survey 
PCCEK manager Quarterly 
Length of enrollment in CHARM-KY Participant 
record 
Program coordinator Quarterly 
 
Data collected for the process evaluation will be obtained via the participants’ medical 
records, referral forms, and the partnership/staff/participant surveys. During the planning phase, 
the program coordinator will be responsible for collecting and compiling results from the focus 
groups and key informant interviews. Providers in the community will complete a referral form 
for woman they refer to CHARM-KY, regardless if the woman chooses to enroll. The PCCEK 
Clinic Manager will compile referral forms on a quarterly basis. The sources will be evaluated to 
determine if recruitment methods should be adapted. When a woman is enrolled in the CHARM-
KY program, the PCCEK manager will complete an intake form.  
To monitor the engagement of key stakeholders in the program, surveys will be 
distributed quarterly to staff and collaboration members, and on a rolling basis to participants. 
	
	
Rice 29 
Findings from these surveys will be discussed by the Leadership Team on a quarterly basis and 
presented to the collaboration members. Participating women will be surveyed at their first and 
fifth CHARM-KY encounter, at the first visit following birth, and at the conclusion of their 
enrollment. This survey will evaluate the mother’s perception of the program, its application and 
impact on her and her family, strengths of the program, and areas in need of improvement.  
The monthly meeting minutes will be analyzed to determine how much time is spent 
discussing patient cases versus program implementation issues. Monitoring the number of 
participants in the group sessions will help program staff identify the need to adjust clinic 
days/times, topics for group discussion, and outside forces that are interfering with participation.  
The CARE Notebook will be evaluated by the first five participants in the program to 
ensure that the resources are relevant, written at the appropriate literacy level, and that it is well 
received before continued use. To ensure that mothers are being adequately educated, each group 
educator (i.e., nurse educator, drug and alcohol counselor) should utilize the teach-back method 
with the program director annually. Many different professionals will be leading the group 
education sessions, and the program director should use a checklist to evaluate each educator’s 
delivery and ensure fidelity across sessions. Process evaluation results will be presented at the 
annual CAG meetings and each quarter at the CHARM-KY member meetings.  
 
Outcome Evaluation 
The target population of this intervention is a sensitive and transient one, making 
outcomes comparison challenging. The outcomes measured will be similar to those evaluated in 
the Vermont CHARM program. The primary outcomes used to evaluate the Vermont CHARM 
program included: gestational age when the woman entered treatment, birth weight, infant 
	
	
Rice 30 
discharge in maternal care, and infant in maternal care at one year12. Baseline demographic data 
from women and neonates in the CHARM-KY program will be compared against data for 
women and their neonates who were referred to CHARM-KY, but chose not to enroll. This data 
will come from referral forms completed by community referral sites. The outcome evaluation of 
CHARM-KY will be conducted by comparing outcomes of participants to regional and state 
level data. The program will partner with the Kentucky Department of Public Health to obtain 
maternal-child health data. Data will be collected and recorded securely in REDCap. A Data 
Analyst from the Center for Excellence in Rural Health will extract pertinent data via chart 
review. Each woman will be given a unique identifier to be used in analysis. A dose effect 
analysis will be conducted to determine if the number of prenatal appointments, counseling 
sessions, use of the Care Notebook, attended has any impact on illicit drug use and birth outcome 
measures. A survey administered to participants will include questions from the Interpersonal 
Support Evaluation List to measure social support39. Results will be discussed with the CAG 
meetings annually.  
Table 5. Outcome Measures. 
Outcome Measure Data Source(s) Responsible 
Person(s) 
Time Frame 
Number of NICU admissions Medical record CEHR Data Analyst Annually 
Birth weight < 2500 grams  Medical record CEHR Data Analyst Annually 
Proportion of infants delivered at < 37 
weeks 
Medical record CEHR Data Analyst Annually 
Length of hospital stay Medical record CEHR Data Analyst Annually 
Adequate prenatal care (80% of 
recommended visits received)  
Medical record CEHR Data Analyst Annually 
Number of Prenatal visits attended  Medical record CEHR Data Analyst Annually 
Self-efficacy in parenting Participant survey CEHR Data Analyst Annually 
Perception of positive social support Participant survey CEHR Data Analyst Annually 
Intent to remain sober Participant survey CEHR Data Analyst Annually 
Infant in maternal care at delivery 
discharge  
Medical record CEHR Data Analyst Annually 
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Number of drug screens negative for 
illicit substances at delivery  
Medical record CEHR Data Analyst Annually 
Gestational age at start of CHARM-
KY 
Medical record CEHR Data Analyst Annually 
Number of women sober at discharge 
from program 
Medical record CEHR Data Analyst Annually 
Participation rate in HANDS CHARM record CEHR Data Analyst Annually 
Infant in maternal care at 1 year CHARM record CEHR Data Analyst Annually 
Uptake of social services CHARM record CEHR Data Analyst Annually 
 
 
Capacity and Experience of the Applicant Organization 
The mission of the Kentucky River District Health Department (KRDHD) is to “protect, 
maintain, and promote the health of the people of the community”40. This department is a 
regional health department that serves seven of the eight counties in the KRADD: Knott, Lee, 
Leslie, Letcher, Owsley, Perry and Wolfe. The application for funding aligns with the goals of 
the organization’s mission statement to connect groups and agencies to improve the access and 
provision of healthcare and social services, including to pregnant women with OUD in the 
district.  
The department has experience in implementing multiple programs in the community, 
including: Breastfeeding classes, Breastfeeding support groups, Ladies’ Health Days, Freedom 
from Smoking classes, Diabetes Self-Management Education classes, Eating Health in Kentucky 
Cooking School, and a partnership with HANDS program. Participants in the District’s Freedom 
from Smoking Classes are 85% more likely to quit40. In 2016, over 150 individuals participated 
in the smoking cessation classes. During Ladies’ Health Days, the District coordinates physical 
exams, pap smears, breast exams, and appropriate lab work for participants41. They frequently 
partner with local schools to host educational programs to the public on topics such as driving 
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under the influence, teen pregnancy, hand hygiene, and physical activity. Most closely related to 
CHARM-KY is the department’s experience in providing prenatal services.  
The KRDHD is led by Public Health Director Dr. Scott Lockard. Dr. Lockard has over 20 
years’ experience in public health leadership and programming. He has served as the primary 
investigator on the HANDS project and was instrumental in starting needle exchange programs 
in the district. His experience in the field of early childhood programming will be advantageous 
to CHARM-KY. He has been awarded over $4 million in grant awards for community programs 
and public health research in the topics of women’s health, published in the American Journal of 
Public Health and the Journal of Obstetric, Gynecologic, & Neonatal Nursing. He has led 
numerous community health needs assessments and shared findings with community action 
councils. Annually, he manages a budget of over $1,250,000 and serves as the direct supervisor 
of over 40 employees.   
 
Project Management 
Leadership 
To meet the above goals, the CHARM-KY Collaborative will be guided by the 
Leadership Team. The Leadership Team will be responsible for overseeing all aspects of 
program implementation and evaluation. They will serve as the ultimate decision making body 
and represent the interests of the partners and participants. The Leadership Team will consist of: 
• Tim Stockton, DrPH, MSW, CSW (CHARM-KY Program Director) 
• Jordan Rice, MPH (CHARM-KY Program Coordinator) 
• Leslie Atkins, RN (CHARM-KY Assistant Coordinator, PCCEK Coordinator) 
 
Tim Stockton, DrPH, MSW, CSW, will serve as the program director (PD). Dr. Lockard 
earned his Master of Social Work and Doctor of Public Health from the University of Kentucky, 
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and is a 2011 graduate of the National Public Health Leadership Institute. Dr. Lockard currently 
serves as the Public Health Director for the Kentucky River District Health Department 
(KRDHD), and is past president of the Kentucky Health Departments Association. He will be 
responsible for the program design, implementation, process and outcome evaluation, and 
dissemination of final program results. 
Jordan Rice, MPH, will serve as the project coordinator. Jordan earned her Master of 
Public Health from the University of Kentucky and currently serves as Public Health Program 
Specialist for the KRDHD. Ms. Rice has led the implementation of programs in the region 
including Ladies Health Days, Breastfeeding classes, and Freedom from Smoking classes. As the 
project director, she will be responsible for (1) management and engagement of key 
stakeholders, including oversight of and communication with CHARM-KY partners and the 
CAG, (2) staff training, (3) data collection, and (4) monitoring program implementation. Ms. 
Rice will organize and lead monthly meetings with the entire CHARM-KY Collaborative team 
to provide updates on the program and discuss care for current participants.  
Leslie Atkins, BSN, RNC-OB, will serve as the Assistant Coordinator and PCCEK 
Coordinator. She has served as Program Director for the Pregnancy and Beyond program at the 
PCCEK clinic for five years. She worked for 10 years as a labor and delivery nurse before 
transitioning to her role at PCCEK. Ms. Adams earned her Bachelor of Science in Nursing at 
Morehead State University and is certified in Obstetrics. Her role in CHARM-KY will be 
primarily administrative; she will (1) manage the recruitment, enrollment, and management of 
program participants, (2) act as liaison for the PCCEK clinic to the CHARM-KY Leadership 
Team, and (3) oversee daily clinic operations. She will focus on participant satisfaction and care 
coordination.  
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Staff 
Medical professionals, as well as mental health support staff, are key to the 
implementation of CHARM-KY.  Dr. John McKinney, MD, is a dual board certified Maternal-
Fetal Medicine and Addiction Medicine physician. He is a certified Buprenorphine provider in 
accordance with the Drug Addiction Treatment Act of 2000 and is currently a practicing partner 
of PCCEK. He will provide both obstetric and mental health care to program participants, 
including examinations, prenatal management, and providing prescriptions for MAT. Michelle 
Hatton, RNC-OB, is currently on staff at PCCEK and provides prenatal nursing care. The nurse 
will be responsible for conducting group classes on prenatal care, fetal development, 
breastfeeding, and parenting, for example. The nurse will also work closely with HANDS to 
coordinate post-partum in-home visitation for participants. Jill Powell, CADC, is a certified 
alcohol and drug counselor at Mountain Comprehensive Care Center in Hazard. Other staff that 
we will recruit for include a social worker and a data analyst. The data analyst will be 
contracted from the Center for Excellence in Rural Health to extract pertinent data from medical 
records and compile information for evaluation. Each month, all representatives from the 
collaborative agencies will meet for 2 hours to discuss participants new to the program, 
participants expected to give birth in the next 30 days, participants who have recently given 
birth, and participants that any agency has concerns about.  
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Budget Narrative 
Grant budget period: July 1, 2018 – June 31, 2021 
A. Anticipated Enrollment. 
Year 1 Year 2 Year 3 TOTAL 
15 30 40 85 
 
The number of women who will participate in CHARM-KY is estimated from the number of live 
births in the KRADD annually, the rate of NAS in the region, and participation in the Vermont 
CHARM program. In the Vermont CHARM program, 15 women were treated during the first 
year, 24 during the third year, and 51 during the fifth year12. The average number of births in the 
KRADD annually from 2014-2016 was 1,36742, and the rate of NAS in KRADD is estimated at 
63.9 per 1,000 births18. With this data, we estimate that at least 85 women would be eligible for 
enrollment in CHARM-KY annually. This information has been used to estimate a total grant 
period enrollment goal of 85; with 15, 30, and 40 in the first, second, and third years of the grant 
respectively.  
 
B. Personnel Salaries and Wages. 
Position Title Annual 
Salary 
% FTE Salary Fringe Total 
Principal Investigator $130,000 20% 
 
$26,000 $7,611 $33,611 
Program Coordinator 
 
$80,000 70% $56,000 $19,202 $75,202 
Assistant 
Coordinator/PCCEK 
Manager 
$52,000 
 
30% $15,600 $6,445 $22,045 
Registered Nurse 
 
$50,000 20% $10,000 $4,211 $14,211 
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Maternal-
Fetal/Addiction 
Medicine Physician 
$225,000 20% $45,000 $11,649 $56,649 
Certified Alcohol and 
Drug Counselor 
$35,000 10% $3,500 $1,787 $5,287 
Social Worker 
 
$45,000 20% $9,000 $3,999 $12,999 
TOTAL PERSONNEL   $168,100 $56,585 $224,685 
Table above reflects budget for Year 1. 
Most the CHARM Collaborative budget will be dedicated to supporting personnel and licensed 
healthcare providers. The CHARM-KY principal investigator will oversee the implementation of 
the program, but the Program Coordinator will manage the program on a daily basis. The 
Program Coordinator will spend the majority of her efforts on program implementation and 
management of all collaboration agencies. The PCCEK Manager will coordinate the program’s 
implementation at the PCCEK Clinic specifically, and should 1.5 to 2 days/week to work on 
program activities. Medical professionals are necessary for this project as they possess the 
training and licensure required for the diagnosis, management, and authority to write 
prescriptions of OUD treatment and care. A specialized license is required by Federal and 
Kentucky State law for medical doctors to write prescriptions for MAT, and the specialization of 
the dual board certified physician is ideal for the CHARM-KY program. Registered nurses are 
necessary to appropriately meet the specialized medical, prenatal, and behavioral health needs of 
individuals in this program. The medical providers will receive reimbursement equal to what 
they would make in their full-time position. During the first year, staff will need to be trained in 
program implementation. During this time, experts from the CHARM Collaborative in Vermont 
will be invited to speak to and train our team. Their insight into the development and 
implementation of this project is imperative for a successful beginning. Our budget will allow for 
compensation for this individual’s time, travel, and lodging in Kentucky.  
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Contractual 
CHARM-KY will contract professionals in data analysis and management to aid in program 
evaluation. A biostatistician from the University of Kentucky will be hired on a contractual basis 
to perform analysis of program data during years 2 and 3 (salary $85,000). CHARM-KY will 
hire a data analyst from the Center for Excellence in Rural Health to extract data from health 
records and record that data in REDCap during years 2 and 3 (salary $45,000). 
 
C. Supplies.  
Item Number 
needed 
Unit cost Year 1 Year 2 
 
Year 3 
Monthly 
meeting food 
Variable $145/meeting $1750 $1750 $1750 
Care 
notebook 
90 $30 $900 
 
$900 $750 
Save-A-Lot 
Gift Card 
70 $20 $600 $600 $200 
Car Seat 
 
90 $100 $3000 $3000 $2500 
Gift card for 
infant 
supplies 
100 $25 $1000 $1125 $375 
Total 
supplies 
  $7250 $7375 $6325 
 
 
Supplies required for program implementation include materials to make the Care Notebooks, 
participant incentives, and food for collaboration meetings. We will overestimate supplies 
needed during the first year (n=30), in case there is a higher enrollment than anticipated. The 
following will be required for notebooks: printer paper, 3-ring binders, printer ink, pens, and 
notepads. During the first year, 20 notebooks will be made, with 30 and 50 made the following 
years based on anticipated enrollment. We estimate each notebook will cost $30 to produce. 
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Each participant will be given the opportunity to earn incentives. Participants will be given $20 
gift cards to Save-A-Lot for each referral made. She will earn a car seat estimated at $100 prior 
to birth if they attend 80% of recommended sessions. If the woman decides to become a peer 
support specialist after graduation from the program, she can earn $25 gift cards for infant 
supplies, such as diapers, for each group session she conducts. Participants will also earn $25 gift 
cards for completing participant surveys. Food will be provided to at least 12 collaboration 
members at each monthly meeting at an estimated cost of $125/meeting.  
 
C. Travel.  
 Year 1 Year 2 Year 3 
APHA Annual 
Meeting Registration 
$1,000 $1,000 $1,030 
Flight $1,000 $1,000 $1,000 
Lodging $1,000 $1,000 $1,000 
Local State Travel $2,000 $1,000 $1,000 
TOTAL $5,000 $4,000 $4,030 
 
Our program leadership will travel locally in the district to train personnel, promote the program, 
and oversee implementation. The furthest county seat from Hazard is Campton, KY in Wolfe 
County at 49 miles. We estimate that the Leadership Team will travel throughout the district 
more frequently during the first year than in subsequent years. At the standard reimbursement 
rate of 53.5 cents/mile, we will estimate travel throughout the district at $2,000 in year one, and 
$1,000 in years two and three.  
Promotion and dissemination of the project and its results will be an important 
contribution to the public health and substance abuse community. Our project background and 
methods will be presented by two staff members at the American Public Health Association 
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annual meeting at the end of year one, preliminary outcome results at the end of year two, and 
final results at the end of year three. The budget will account for meeting registration, lodging, 
and travel to present our project findings across all three years of the grant. The 2019 annual 
meeting is in Philadelphia. Our grant will budget $1,000 for registration, $500/ticket for airfare, 
and $250/night for lodging for two rooms for nights at an estimated total attendance cost of 
$3,000.  
 
D. Equipment. 
 CHARM-KY will require no additional equipment outside of the already established 
clinic; services, exams, medications and lab tests will be paid for by insurance. 
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Appendix A. Description of accountability level system32. 
 
 
 
 Level of Accountability in CHARM-KY 
Level Criteria Prescription Policy 
1 Negative drug screens for at least 1 month and  
No reported relapse in the last month and 
1 or less missed appointments 
Prescriptions are written 
for a maximum of 14 
days 
2 Positive drug screen for illicit drug use and/or  
Reported relapse within the last two months and/or 
2 missed appointments within the last month 
Prescriptions are written 
for a maximum of 7 days 
3 History of habitual illicit drug use and/or  
Reported relapse within the last month and/or  
3 or more missed appointments within the last month  
Prescriptions are written 
for a maximum of 4 days 
or until next appointment 
Adapted from PATHways Phase System Overview. 
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Appendix B. Patient information and data to be collected. This list serves as an example of data 
to be collected and is not conclusive. 
• Demographic 
o Number of children 
o Marital status 
o County of residence 
o Employment status 
o Education completed 
o Housing status 
o Transportation status 
o Insurance status 
o Age 
• Medical (behavioral health) 
o Mental health conditions 
o Drug use (substance, route of use) 
o History of recovery attempts 
• Medical (obstetrics)  
• Medical (other) 
o Other health conditions 
o Tobacco use 
• Neonatal 
o Birth weight  
o Gestational age at birth 
o Drug screen of neonate at birth  
o Treatment required for NAS 
o NICU admission 
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Appendix C. CHARM-KY Materials. 
 
Examples of education topics: 
• Breastfeeding 
• Giving birth 
• Nutrition for newborn 
• Nutrition during pregnancy 
• Birth control and family planning 
• Domestic violence 
• Financial planning (balancing checkbook, etc) 
• Applying for jobs 
• Decision making 
• Smoking cessation 
	
	
 
 
 
 
The Four P’s Plus screening tool33: 
 
 
 
 
 
Logic	Model
Inputs Activities Outputs Early	Outcomes
Later	
Outcomes
Funding	
Agency
Provide	
Prenatal	Care
Uptake	in	
prenatal	care	
services
Adequate	
prenatal	care
Improved	
neonatal	
health	
outcomesMedical	
Personnel
Community	
Partners
PCCEK	Clinic
CHARM	
Vermont
Provide	
Medication	
Assisted	
Treatment
Connection	to	
services
Women	
engaged	in	
substance	
treatment
Uptake	of	
social	services
Reduction	in	
illicit	drug	use
Post-natal	
care
Improved	
child	safety
Maintenance	
of	recovery
Program	is	
broadly	
adopted
Increased	
engagement	in	
treatment
Increased	health	
outcomes	at	
birth
Increased	self-
efficacy	in	
parenting
Group	
education
July	1,	2018	-	June	31,	2021
Effort Salary Fringe Total Effort Salary Fringe Total Effort Salary Fringe Total
Personnel
Principal	Investigator 20.00% $130,000 $26,000 $7,611 $33,611 10.00% $133,900 $13,390 $3,889 $17,279 10.00% $137,917 $13,792 $3,974 $17,766
Program	Coordinator 70.00% $80,000 $56,000 $19,202 $75,202 80.00% $82,400 $65,920 $22,354 $88,274 80.00% $84,872 $67,898 $22,774 $90,671
Assistant	Coordinator/PCCEK	Manager 30.00% $52,000 $15,600 $6,445 $22,045 30.00% $53,560 $16,068 $2,922 $18,990 40.00% $55,166 $22,066 $3,953 $26,019
Registered	nurse,	Obstetrics 20.00% $50,000 $10,000 $4,211 $14,211 20.00% $51,500 $10,300 $1,912 $12,212 30.00% $53,045 $15,914 $2,908 $18,822
Maternal/Fetal/Addiction	MD 20.00% $225,000 $45,000 $11,649 $56,649 20.00% $231,750 $46,350 $5,102 $51,452 20.00% $238,702 $47,740 $5,225 $52,965
Certified	Alcohol	and	Drug	Counselor 10.00% $35,000 $3,500 $1,787 $5,287 20.00% $36,050 $7,210 $1,638 $8,848 10.00% $37,131 $3,713 $829 $4,542
Social	Worker 20.00% $45,000 $9,000 $3,999 $12,999 30.00% $46,350 $13,905 $2,731 $16,636 30.00% $47,740 $14,322 $2,767 $17,089
Biostatistician 0.00% 5.00% $85,000 $4,250 $626 $4,876 10.00% $87,000 $8,700 $1,270 $9,970
CEHR	Data	Analyst 0.00% 20.00% $45,000 $9,000 $1,797 $10,797 40.00% $47,000 $18,800 $3,664 $22,464
Trainers	from	Vermont $5,000 $0 $0
Personnel	Total $165,100 $54,904 $225,004 $173,143 $40,546 $229,362 $185,445 $42,430 $260,308
Program	Supplies 15	participants
Monthly	meeting	food $1,750 $1,750 $1,750
Incentives $4,600 30	participants $4,725 40	participants $3,825
Care	Notebooks $900 $900 $750
Program	Total $7,250 $7,375 $6,325
Travel
APHA	Annual	Meeting	registration 2	staff	members $1,000 $1,000 $1,030
Flight 2	staff	members $1,000 $1,000 $1,000
Lodging 2	staff	members $1,000 $1,000 $1,000
Local	travel $2,000 $1,000 $1,000
Travel	Total $5,000 $4,000 $4,030
ANNUAL	TOTAL $237,254 $240,737 $270,663
GRAND	TOTAL	(Year	1	+	2	+	3) $748,655
Year	1 Year	2 Year	3
Task Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Planning	phase
Conduct	focus	groups
Connect	with	community	partners
Staff	training
Meet	with	CAG
Submit	abstract	to	APHA
Participant	surveys
Process	evaluation
Process	evaluation	dissimination	
Develop	CARE	Notebook
Program	enrollment	open
Present	at	APHA	meeting
Outcome	evaluation
Prepare	manuscripts
Year	1 Year	2 Year	3
